
Tackling Malaria
We are focused on better understanding the deadly parasites that cause human malaria.
We are focused on better understanding the deadly parasites that cause human malaria.
We are focused on better understanding the deadly parasites that cause human malaria.
Malaria is a major cause of death in the Asia-Pacific, infecting around 250 million people each year.
The Menzies malaria research program spans a broad range of research activities aimed at both prevention and treatment, from epidemiology, diagnosis, pathophysiology, immunology, molecular parasitology, clinical trials, and evaluation of the impact and cost-effectiveness of public health interventions.
We work on all five species of the Plasmodium parasite that cause human malaria, with a particular focus on the three that cause most disease and death in the Asia-Pacific region: P. falciparum, P. vivax and P. knowlesi.
Australian:
International
Implementation of G6PD testing: challenges and opportunities by Dr Ben Ley
Cost-effectiveness modelling and malaria by Dr Angela Devine
#MalariaWeek: Harnessing innovation to accelerate malaria elimination and strengthen health security
User perspectives on a quantitative G6PD test in Bangladesh
A training for health service providers on the SD Biosensor STANDARD G6PD test in Bangladesh
Vivax: Optimizing radical cure for vivax malaria: Informing policy and practice
Clinical trials to improve radical cure of P. vivax by Dr Kamala Thriemer
Designing chloroquine dosing regimens for COVID-19 clinical trials by Prof Ric Price and Prof Julie Simpson
The goal of eliminating malaria is one-step closer thanks to a an NHMRC Ideas grant to Menzies senior research fellow Dr Sarah Auburn.
CDU Research Impact story | Menzies researcher Dr Kamala Ley-Thriemer is committed to the cause.
Completing his PhD with CDU through the Menzies School of Health Research, Damian Oyong has made a significant contribution to fighting the disease.
Research findings by Charles Darwin University PhD graduate Dr Robert Commons has the potential to deliver health benefits to millions of malaria sufferers around the globe.
Signed by clinicians, medical researchers, statisticians, and ethicists from across the world, follows the publication of a paper on using hydroxychloroquine or chloroquine for the treatment of COVID-19.
Report on Menzies NHMRC and MRFF Investigator grants.
Five researchers based at Menzies have received recognition in the form of Investigator Grants from the NHMRC and the MRFF.
Including Menzies School of Health Research work towards the elimination of chronic hepatitis B in the Northern Territory.
The elimination of malaria from the Asia Pacific within the decade will require the safe and effective radical cure of malaria, a new paper in Trends in Parasitology suggests.
The elimination of malaria from the Asia Pacific within the decade will require the safe and effective radical cure of malaria, a new paper in Trends in Parasitology suggests.
Menzies investigators and international collaborators have published a meta-analysis and identified a point of care test for the diagnosis of G6PD deficiency with suitable reliability for routine use. Further feasibility studies are under way to assess its reliability under field conditions.
Menzies School of Health (Menzies) researcher Dr Kamala Thriemer has been awarded a prestigious $1.25 million CSL Centenary Fellowship to develop and optimise treatment programs against vivax malaria in SE Asia and the Horn of Africa.
Two Australian scientists have each been awarded AUD$1.25 million CSL Centenary Fellowships over five years to improve treatments for two of the world’s biggest health challenges: malaria and cancer.
A new research study has shown that a seven-day treatment with a high dose of an anti-malaria drug can be tolerated by patients
A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated.
MESA Correspondents bring you cutting-edge coverage from the 7th International Conference on Plasmodium vivax Research (ICPVR 2019).
Wrapping up the 7th International Conference on Plasmodium vivax Research, day three focused on the topics of P. vivax drugs and approaches for P. vivax elimination.
National Tribune Online news | Graduating this week with a PhD, rising star malaria researcher Dr Steven Kho.
Blood platelets, neutrophils and the spleen have novel roles in people with malaria, according to new research from Charles Darwin University (CDU) and Menzies School of Health Research.
Prof Ric Price recognised by The Academy of Medical Sciences as one of 50 of the UK’s leading figures elected to their esteemed Fellowship.
Professor Richard Price , Professor of Global Health and Senior Principal Research Fellow, Menzies School of Health Research, and Professor of Tropical Medicine, University of Oxford
The largest grant, of $257,767, goes to the Menzies School of Health Research for a project with collaborators in Bangladesh, Indonesia and the Netherlands.
Among the other projects funded are the Menzies School of Health Research partnering with Bangladesh, Indonesia and Nepal to develop malaria treatments.
Could a new defence against malaria be found in human blood? Research suggests that human platelets — a component of the blood — form a first-line defence against the malaria parasite.
The first new treatment in 60 years for a particularly stubborn kind of malaria is raising hopes that it might help eradicate the disease.
Australian and Papua New Guinean research groups will work in partnership to address malaria, tuberculosis and other health security threats, under a new grants program funded by the Australian government.
The study, which has just been published in the prestigious journal Blood, was led by Associate Professor Brendan McMorran at ANU and Professor Nick Anstey at Darwin's Menzies School of Health Research
The study, published by the Menzies School of Health Research (MSHR) in Australia's Northern Territory (NT), revealed that platelets attack and kill malaria parasites in the bloodstream.
The humble platelet is usually regarded as just a tiny cell that helps the blood clot. A study just published in the prestigious journal Blood has found that platelets attack and kill malaria parasites in infected humans to reduce the number of parasites circulating in their blood.
A study, led by a team at Menzies School of Health Research in Australia, has assembled individual patient data from clinical trials conducted since 2000, investigating the effect of chloroquine dosing, combined with the partner drug primaquine, and the risk of recurrent malaria across different settings.
NT News page 7 - 21 July 2018 | Report on The Lancet Infectious Diseases P.vivax paper.
(Xinhua) -- Researchers have discovered that a "radical cure" is the best treatment for a type of malaria affecting 13 million people.
A team of malaria experts from a large international research collaboration has today published results supporting the need for a radical cure strategy to tackle one of the most debilitating forms of malaria caused by the Plasmodium vivax parasite.
Australia is playing a leading role in supporting malaria elimination efforts, particularly in the Indo-Pacific. The Government's Stronger Systems for Health Security program is supporting practical, relevant research into fundamental health security challenges.
Malaysia’s national malaria eradication program has successfully reduced infections associated with Plasmodium falciparum and vivax malaria. to the point where these species may realistically be eradicated by 2020. Plasmodium knowlesi malaria is now...
Menzies is investing and developing expertise in the emerging research area of genome sequencing. In the past year, we took the lead in a number of national and international collaborative programs investigating the genomics of tropical pathogens, and...
We would like to thank all the sites and study staff for all their hard work. This has been a huge undertaking over the past few years which will yield important results to optimise vivax malaria treatment regimens.
Malaria expert Professor Ric Price, from the Menzies School of Health Research in Darwin, said advising travellers about the prevention of malaria was not straightforward.
Matthew Grigg is a senior research fellow at the Menzies School of Health Research and spent several years researching mosquitoes and malaria while living in a small town called Kudat in Sabah, Malaysia.
A DARWIN scientist has been named the Young Tall Poppy Scientist of the Year in recognition of his research into a type of monkey malaria transmitted to humans via mosquitoes.
Dr Matthew Grigg's research into monkey malaria has already changed WHO treatment guidelines and saved lives across Southeast Asia, writes Sarah Condie - Cosmos Magazine
THE quest to develop a better malaria vaccine is a complicated business, but that hasn't deterred Dr Jessica Loughland, of the Menzies School of Health Research, who received a PhD yesterday from Charles Darwin University
Menzies School of Health Research clinical research fellow Dr Matthew Grigg has been named the 2017 NT Young Tall Poppy Scientist of the Year.
Researchers at Darwin's Menzies School of Health Research will play a key role in a new push to fight the scourge of malaria in the Asia-Pacific region.
Menzies School of Health Research (Menzies) clinical research fellow Dr Matthew Grigg has been named the 2017 NT Young Tall Poppy Scientist of the Year in recognition for ongoing research into Plasmodium knowlesi (P. knowlesi) malaria, a type of monkey malaria transmitted to humans via mosquitos in Southeast Asia.
Australia will take a leadership role in the Asia-Pacific region in a new initiative to help our nearest neighbours rid the scourge of malaria, in a new National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Malaria Elimination.
Professor Ric Price is an expert in malaria who works at the Menzies School of Health Research in Darwin. He said the victory over malaria was a result of prompt and effective diagnosis, actions to control mosquito numbers, and close follow-up of people who returned home from overseas who were sick with malaria.
Matthew J Grigg, of the Menzies School of Health Research in Darwin, Australia and Georges Snounou, of the Sorbonne University in Paris, France, say it is imperative that studies establish whether this is the simium parasite or whether it might be a reservoir of vivax in Brazilian monkeys, which “would pose a substantial threat to malaria elimination throughout the continent and possibly beyond”
A study led by the Menzies School of Health Research recommends a two-stage treatment for the notoriously difficult-to-cure Plasmodium vivax malaria
A study into the treatment of the difficult-to-cure Plasmodium vivax malaria in Ethiopia.
An international team of scientists has sequenced the genomes of the final two species of malaria parasites. The findings have important implications for malaria eradication worldwide and will help researchers to develop new drugs and a vaccine.
A $2m research grant to work towards the prevention, control and elimination of malaria and tuberculosis (TB) in Southeast Asia and the Pacific has been awarded to a consortium led by Menzies School of Health Research, in collaboration with Burnet Institute, the Department of Foreign Affairs and Trade announced today.
Two inspiring health researchers from Menzies School of Health Research (Menzies) were awarded prestigious National Health and Medical Research Council (NHMRC) Research Excellence Awards last night in Canberra.
A medical team based in Darwin has put itself at the centre of the goal to eliminate malaria from the Asia-Pacific
New research into the malaria parasite Plasmodium vivax has provided insights into why people infected with this malaria species may develop severe disease.
New research into the extent and nature of drug resistant malaria is hoping to benefit the millions of people worldwide who suffer from the potential deadly disease.
A new study by a global collaborative platform for scientists and clinical researchers hopes to address antimalarial drug resistance which continues to hamper malaria control programs.
Scientists say new research into malaria will help provide new ways to combat the deadly disease.
Scientists say new research into the malaria parasite will provide drugs to combat the ways it's evolving to gain resistance to the current range of anti-malaria medicine.
Countries around the world need to do more to fight the spread of malaria, according to a new report by the World Health Organisation (WHO).
The millions of people worldwide who suffer from malaria and other tropical infections each year will benefit from the awarding of a federal fellowship to one of the country's leading clinical researchers in tropical health.